The single-use bioreactor market is expected to register a CAGR of nearly 21.6% during the forecast period, 2019-2025.
Single-use Bioreactors Market by Product (Single-use Bioreactor, Media Bags, Filtration Assembly, Others), Usage (Lab-scale, Pilot Scale, Large-scale), Type (Stirred tank, Wave-Induced, Bubble-Column, Others), Cell Type (Mammalian, bacterial, Yeast, Other
(EMAILWIRE.COM, January 15, 2020 ) Meticulous Research® – leading global market research company is researching on Single-use Bioreactors Market titled- “𝐒𝐢𝐧𝐠𝐥𝐞-𝐮𝐬𝐞 𝐁𝐢𝐨𝐫𝐞𝐚𝐜𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 (𝐒𝐢𝐧𝐠𝐥𝐞-𝐮𝐬𝐞 𝐁𝐢𝐨𝐫𝐞𝐚𝐜𝐭𝐨𝐫, 𝐌𝐞𝐝𝐢𝐚 𝐁𝐚𝐠𝐬), 𝐔𝐬𝐚𝐠𝐞 (𝐋𝐚𝐛-𝐬𝐜𝐚𝐥𝐞, 𝐋𝐚𝐫𝐠𝐞-𝐬𝐜𝐚𝐥𝐞), 𝐓𝐲𝐩𝐞 (𝐒𝐭𝐢𝐫𝐫𝐞𝐝 𝐭𝐚𝐧𝐤, 𝐁𝐮𝐛𝐛𝐥𝐞-𝐂𝐨𝐥𝐮𝐦𝐧), 𝐜𝐞𝐥𝐥 𝐭𝐲𝐩𝐞 (𝐌𝐚𝐦𝐦𝐚𝐥𝐢𝐚𝐧, 𝐛𝐚𝐜𝐭𝐞𝐫𝐢𝐚), 𝐚𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 (𝐁𝐢𝐨𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧, 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡), 𝐄𝐧𝐝 𝐮𝐬𝐞𝐫 (𝐏𝐡𝐚𝐫𝐦𝐚 & 𝐛𝐢𝐨𝐭𝐞𝐜𝐡, 𝐂𝐑𝐎𝐬)- 𝐆𝐥𝐨𝐛𝐚𝐥 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟓".
𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞 𝐢𝐧 𝐆𝐨𝐯𝐞𝐫𝐧𝐦𝐞𝐧𝐭 𝐒𝐮𝐩𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐁𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐎𝐟𝐟𝐞𝐫𝐬 𝐍𝐞𝐰 𝐆𝐫𝐨𝐰𝐭𝐡 𝐀𝐯𝐞𝐧𝐮𝐞𝐬 𝐟𝐨𝐫 𝐒𝐢𝐧𝐠𝐥𝐞-𝐮𝐬𝐞 𝐁𝐢𝐨𝐫𝐞𝐚𝐜𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭
Governments in developed as well as developing nations are offering funding for propagation of biotechnology and biopharmaceutical research. For instance, in India, in 2017, Department of Biotechnology (DBT) and World Bank initiated a program - Innovate in India (I3) - to facilitate research related to the discovery of biopharmaceuticals. Similarly, in the U.S., National Institute of Health (NIH) collaborated with 11 biopharmaceutical companies to launch the “Partnership for Accelerating Cancer Therapies (PACT)”, a five-year public-private research collaboration. The aim of the collaboration is to develop immunotherapy for cancers with total investment of $215 million. Furthermore, in Korea, the government announced second Basic Development Plan for Bioengineering (2012). According to which, the Korean government increased biotech investments to KRW 9.7 trillion ($8.35 billion) through 2016. In addition, Korean government announced the “Government-Wide Mid- to Long-Term Action Plans to Promote R&D for National Healthcare” in 2013 - to promote growth of biotechnology and healthcare industry.
𝐆𝐞𝐭 𝐚 𝐬𝐚𝐦𝐩𝐥𝐞 𝐜𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐩𝐫𝐞𝐦𝐢𝐮𝐦 𝐫𝐞𝐩𝐨𝐫𝐭: -
https://www.meticulousresearch.com/request-sample-report/cp_id=5005
𝐒𝐢𝐧𝐠𝐥𝐞-𝐔𝐬𝐞 𝐁𝐢𝐨𝐫𝐞𝐚𝐜𝐭𝐨𝐫 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐒𝐞𝐠𝐦𝐞𝐧𝐭 𝐃𝐨𝐦𝐢𝐧𝐚𝐭𝐞𝐝 𝐭𝐡𝐞 𝐒𝐢𝐧𝐠𝐥𝐞-𝐔𝐬𝐞 𝐁𝐢𝐨𝐫𝐞𝐚𝐜𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝟐𝟎𝟏𝟖
Single-use bioreactor system commanded the largest share of the single-use bioreactors market in 2018 due to its better flexibility, no sterilization demand, and low operational cost without compromising the quality of the drug produced. This addresses the complexities associated with multidrug manufacturing processes while providing maximum savings on the time spent to prepare the bioreactor for the next batch.
𝐌𝐚𝐦𝐦𝐚𝐥𝐢𝐚𝐧 𝐂𝐞𝐥𝐥𝐬 𝐭𝐨 𝐖𝐢𝐭𝐧𝐞𝐬𝐬 𝐭𝐡𝐞 𝐋𝐚𝐫𝐠𝐞𝐬𝐭 𝐃𝐞𝐦𝐚𝐧𝐝 𝐓𝐡𝐫𝐨𝐮𝐠𝐡 𝟐𝟎𝟐𝟓
Mammalian cells commanded the largest share of the single-use bioreactor market in 2018. This is mainly attributed to proper protein folding, post-translational modifications, and product assembly, which plays an important role to initiate complete biological activity in humans.
𝐀𝐬𝐢𝐚-𝐏𝐚𝐜𝐢𝐟𝐢𝐜: 𝐓𝐡𝐞 𝐅𝐚𝐬𝐭𝐞𝐬𝐭 𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭
North America commanded the largest share of the global single-use bioreactors market is 2018, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. However, Asia-Pacific is the fastest-growing regional market due to the accelerated economic growth of many countries in this region and the growing government focus on pharmaceutical research. In addition, government initiatives to escalate the drug development process, rising public & private funding for R&D, and rising contract research and manufacturing activities - are the key factors propelling the growth of the Asia-Pacific single-use bioreactors market.
𝐄𝐧𝐪𝐮𝐢𝐫𝐞 𝐨𝐫 𝐬𝐡𝐚𝐫𝐞 𝐲𝐨𝐮𝐫 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬 𝐢𝐟 𝐚𝐧𝐲 @
https://www.meticulousresearch.com/enquire-before-buying/cp_id=5005
𝐊𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐒𝐢𝐧𝐠𝐥𝐞-𝐮𝐬𝐞 𝐁𝐢𝐨𝐫𝐞𝐚𝐜𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭
In the single-use bioreactors market, the leading players are consistently developing new products with improved performance, higher efficiency, and low operational costs. In March 2018, Sartorius Stedim Biotech launched ambr 250 high throughputs (ht) perfusion system for rapid cell culture perfusion process development for the production of therapeutic antibodies. Similarly, in April 2016, Merck Millipore launched Mobius 1000-liter single-use bioreactor, which has greater flexibility and continuity for scale-up. Furthermore, in November 2016, Finesse Solutions, Inc. (U.S.), launched SmartVessel, a single-use 3-liter bioreactor vessel.
The key players operating in the global single-use bioreactors market are GE Healthcare, Merck Group, Danaher Corporation, Sartorius AG, Thermo Fisher Scientific Inc., Eppendorf AG, Applikon Biotechnology B.V., Solaris Biotechnology SRL, Cellexus Ltd, CESCO Bioengineering Co., Ltd., PBS Biotech, Inc., Pierre Guerin Technologies, Distek, Inc., Parker-Hannifin Corporation, Celltainer Biotech B.V., and Infors AG.
𝐓𝐚𝐛𝐥𝐞 𝐨𝐟 𝐂𝐨𝐧𝐭𝐞𝐧𝐭𝐬
1. Introduction
1.1. Market Ecosystem
1.2. Currency & Limitation
1.2.1. Currency
1.2.2. Limitation
1.3. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Rapid Adoption of Disposable Technology in Pharmaceutical and Biotechnology Industry
4.2.2. Cost-Effectiveness and Lower Downtime of Single-use Bioreactor
4.2.3. Increase in Government Support for Biopharmaceutical Research
4.2.4. Growing Demand for Biopharmaceuticals
4.2.5. Frequent Launch of New Products
4.3. Restraints
4.3.1. High Expenses Due to Recurrent Demand
4.3.2. Extractability and Leachability Issues Related to Disposable Components of Bioreactors
4.3.3. Stringent Regulatory Concerns associated with Single-use Bioreactor
4.4. Challenge
4.4.1. Limited Culturing Capacity
4.5. Opportunities
4.5.1. Significant Opportunities from Emerging Economies
4.5.2. Personalized Medicine to Offer New Growth Potential
4.5.3. Expected Surge in Biosimilar Production in the U.S.
5. Single-use Bioreactor Market, by Product
5.1. Introduction
5.2. Single-use Bioreactor systems
5.2.1. Upto 10L
5.2.2. 11L–100L
5.2.3. 101L–500L
5.2.4. 501L–1500L
5.2.5. Above 1500L
5.3. Media Bags
5.2.1. 2D Bags
5.2.2. 3D Bags
5.2.3. Other Bags
5.4. Filtration assemblies
5.5. Others
…. Continued
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐟𝐫𝐞𝐞 𝐬𝐚𝐦𝐩𝐥𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐚𝐥𝐥 𝐠𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐜𝐡𝐚𝐫𝐭𝐬 𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐭𝐨 𝐢𝐭: -
https://www.meticulousresearch.com/download-sample-report/cp_id=5005
𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞 𝐢𝐧 𝐆𝐨𝐯𝐞𝐫𝐧𝐦𝐞𝐧𝐭 𝐒𝐮𝐩𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐁𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐎𝐟𝐟𝐞𝐫𝐬 𝐍𝐞𝐰 𝐆𝐫𝐨𝐰𝐭𝐡 𝐀𝐯𝐞𝐧𝐮𝐞𝐬 𝐟𝐨𝐫 𝐒𝐢𝐧𝐠𝐥𝐞-𝐮𝐬𝐞 𝐁𝐢𝐨𝐫𝐞𝐚𝐜𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭
Governments in developed as well as developing nations are offering funding for propagation of biotechnology and biopharmaceutical research. For instance, in India, in 2017, Department of Biotechnology (DBT) and World Bank initiated a program - Innovate in India (I3) - to facilitate research related to the discovery of biopharmaceuticals. Similarly, in the U.S., National Institute of Health (NIH) collaborated with 11 biopharmaceutical companies to launch the “Partnership for Accelerating Cancer Therapies (PACT)”, a five-year public-private research collaboration. The aim of the collaboration is to develop immunotherapy for cancers with total investment of $215 million. Furthermore, in Korea, the government announced second Basic Development Plan for Bioengineering (2012). According to which, the Korean government increased biotech investments to KRW 9.7 trillion ($8.35 billion) through 2016. In addition, Korean government announced the “Government-Wide Mid- to Long-Term Action Plans to Promote R&D for National Healthcare” in 2013 - to promote growth of biotechnology and healthcare industry.
𝐆𝐞𝐭 𝐚 𝐬𝐚𝐦𝐩𝐥𝐞 𝐜𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐩𝐫𝐞𝐦𝐢𝐮𝐦 𝐫𝐞𝐩𝐨𝐫𝐭: -
https://www.meticulousresearch.com/request-sample-report/cp_id=5005
𝐒𝐢𝐧𝐠𝐥𝐞-𝐔𝐬𝐞 𝐁𝐢𝐨𝐫𝐞𝐚𝐜𝐭𝐨𝐫 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐒𝐞𝐠𝐦𝐞𝐧𝐭 𝐃𝐨𝐦𝐢𝐧𝐚𝐭𝐞𝐝 𝐭𝐡𝐞 𝐒𝐢𝐧𝐠𝐥𝐞-𝐔𝐬𝐞 𝐁𝐢𝐨𝐫𝐞𝐚𝐜𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 𝟐𝟎𝟏𝟖
Single-use bioreactor system commanded the largest share of the single-use bioreactors market in 2018 due to its better flexibility, no sterilization demand, and low operational cost without compromising the quality of the drug produced. This addresses the complexities associated with multidrug manufacturing processes while providing maximum savings on the time spent to prepare the bioreactor for the next batch.
𝐌𝐚𝐦𝐦𝐚𝐥𝐢𝐚𝐧 𝐂𝐞𝐥𝐥𝐬 𝐭𝐨 𝐖𝐢𝐭𝐧𝐞𝐬𝐬 𝐭𝐡𝐞 𝐋𝐚𝐫𝐠𝐞𝐬𝐭 𝐃𝐞𝐦𝐚𝐧𝐝 𝐓𝐡𝐫𝐨𝐮𝐠𝐡 𝟐𝟎𝟐𝟓
Mammalian cells commanded the largest share of the single-use bioreactor market in 2018. This is mainly attributed to proper protein folding, post-translational modifications, and product assembly, which plays an important role to initiate complete biological activity in humans.
𝐀𝐬𝐢𝐚-𝐏𝐚𝐜𝐢𝐟𝐢𝐜: 𝐓𝐡𝐞 𝐅𝐚𝐬𝐭𝐞𝐬𝐭 𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭
North America commanded the largest share of the global single-use bioreactors market is 2018, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. However, Asia-Pacific is the fastest-growing regional market due to the accelerated economic growth of many countries in this region and the growing government focus on pharmaceutical research. In addition, government initiatives to escalate the drug development process, rising public & private funding for R&D, and rising contract research and manufacturing activities - are the key factors propelling the growth of the Asia-Pacific single-use bioreactors market.
𝐄𝐧𝐪𝐮𝐢𝐫𝐞 𝐨𝐫 𝐬𝐡𝐚𝐫𝐞 𝐲𝐨𝐮𝐫 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬 𝐢𝐟 𝐚𝐧𝐲 @
https://www.meticulousresearch.com/enquire-before-buying/cp_id=5005
𝐊𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐒𝐢𝐧𝐠𝐥𝐞-𝐮𝐬𝐞 𝐁𝐢𝐨𝐫𝐞𝐚𝐜𝐭𝐨𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭
In the single-use bioreactors market, the leading players are consistently developing new products with improved performance, higher efficiency, and low operational costs. In March 2018, Sartorius Stedim Biotech launched ambr 250 high throughputs (ht) perfusion system for rapid cell culture perfusion process development for the production of therapeutic antibodies. Similarly, in April 2016, Merck Millipore launched Mobius 1000-liter single-use bioreactor, which has greater flexibility and continuity for scale-up. Furthermore, in November 2016, Finesse Solutions, Inc. (U.S.), launched SmartVessel, a single-use 3-liter bioreactor vessel.
The key players operating in the global single-use bioreactors market are GE Healthcare, Merck Group, Danaher Corporation, Sartorius AG, Thermo Fisher Scientific Inc., Eppendorf AG, Applikon Biotechnology B.V., Solaris Biotechnology SRL, Cellexus Ltd, CESCO Bioengineering Co., Ltd., PBS Biotech, Inc., Pierre Guerin Technologies, Distek, Inc., Parker-Hannifin Corporation, Celltainer Biotech B.V., and Infors AG.
𝐓𝐚𝐛𝐥𝐞 𝐨𝐟 𝐂𝐨𝐧𝐭𝐞𝐧𝐭𝐬
1. Introduction
1.1. Market Ecosystem
1.2. Currency & Limitation
1.2.1. Currency
1.2.2. Limitation
1.3. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Rapid Adoption of Disposable Technology in Pharmaceutical and Biotechnology Industry
4.2.2. Cost-Effectiveness and Lower Downtime of Single-use Bioreactor
4.2.3. Increase in Government Support for Biopharmaceutical Research
4.2.4. Growing Demand for Biopharmaceuticals
4.2.5. Frequent Launch of New Products
4.3. Restraints
4.3.1. High Expenses Due to Recurrent Demand
4.3.2. Extractability and Leachability Issues Related to Disposable Components of Bioreactors
4.3.3. Stringent Regulatory Concerns associated with Single-use Bioreactor
4.4. Challenge
4.4.1. Limited Culturing Capacity
4.5. Opportunities
4.5.1. Significant Opportunities from Emerging Economies
4.5.2. Personalized Medicine to Offer New Growth Potential
4.5.3. Expected Surge in Biosimilar Production in the U.S.
5. Single-use Bioreactor Market, by Product
5.1. Introduction
5.2. Single-use Bioreactor systems
5.2.1. Upto 10L
5.2.2. 11L–100L
5.2.3. 101L–500L
5.2.4. 501L–1500L
5.2.5. Above 1500L
5.3. Media Bags
5.2.1. 2D Bags
5.2.2. 3D Bags
5.2.3. Other Bags
5.4. Filtration assemblies
5.5. Others
…. Continued
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐟𝐫𝐞𝐞 𝐬𝐚𝐦𝐩𝐥𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐚𝐥𝐥 𝐠𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐜𝐡𝐚𝐫𝐭𝐬 𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐭𝐨 𝐢𝐭: -
https://www.meticulousresearch.com/download-sample-report/cp_id=5005
Contact Information:
Meticulous Research™
chhagan yadav
Tel: +91 744-7780008
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Meticulous Research™
chhagan yadav
Tel: +91 744-7780008
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results